{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:09:24Z","timestamp":1774303764261,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Cholera and Enteric Diseases"},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.vaccine.2017.09.066","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T21:41:39Z","timestamp":1507844499000},"page":"6359-6366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever"],"prefix":"10.1016","volume":"35","author":[{"given":"Debaki Ranjan","family":"Howlader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanta","family":"Koley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhrid","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ushasi","family":"Bhaumik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2017.09.066_b0005","doi-asserted-by":"crossref","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.066_b0010","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Org"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.066_b0015","doi-asserted-by":"crossref","first-page":"020407","DOI":"10.7189\/jogh.05.020407","article-title":"Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever","volume":"5","author":"Azmatullah","year":"2015","journal-title":"J Glob Health"},{"issue":"9973","key":"10.1016\/j.vaccine.2017.09.066_b0020","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0025","doi-asserted-by":"crossref","first-page":"e2925","DOI":"10.1371\/journal.pntd.0002925","article-title":"Estimating the burden of paratyphoid A in Asia and Africa","volume":"8","author":"Arndt","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.066_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/0255-0857.83904","article-title":"Antimicrobial resistance in typhoidal salmonellae","volume":"29","author":"Harish","year":"2011","journal-title":"Indian J Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.09.066_b0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1473-3099(05)70239-5","article-title":"Typhoid and paratyphoid fever in travellers","volume":"5","author":"Connor","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.066_b0040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7150\/ijms.7768","article-title":"Paratyphoid fever: splicing the global analyses","volume":"11","author":"Teh","year":"2014","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.066_b0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1155\/2010\/968960","article-title":"A 10-year retrospective review of Salmonella infections at the Children's Hospital in London, Ontario","volume":"21","author":"Cellucci","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"9180","key":"10.1016\/j.vaccine.2017.09.066_b0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.09.066_b0055","series-title":"Salmonella infections. Clinical, immunological and molecular aspects, advances in molecular and cellular microbiology","author":"Mastroeni","year":"2005"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.066_b0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid Fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0065","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.3390\/ijerph120809692","article-title":"Prevalence of antimicrobial resistant and virulent Salmonella spp. in treated effluent and receiving aquatic milieu of wastewater treatment plants in Durban, South Africa","volume":"12","author":"Odjadjare","year":"2015","journal-title":"Int J Environ Res Publ Health"},{"issue":"14","key":"10.1016\/j.vaccine.2017.09.066_b0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12866-014-0263-x","article-title":"Quantification and characterization of Salmonella spp. isolates in sewage sludge with potential usage in agriculture","volume":"22","author":"Krzyzanowski","year":"2014","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.066_b0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijheh.2005.08.006","article-title":"Isolation of Salmonella serotypes in wastewater and effluent: effect of treatment and potential risk","volume":"209","author":"Espigares","year":"2006","journal-title":"Int J Hyg Environ Health"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0080","first-page":"454","article-title":"Epidemiology of typhoid and paratyphoid fever in India","volume":"2","author":"Kanungo","year":"2008","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/aje\/kwh107","article-title":"A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales","volume":"159","author":"Morris-Cunnington","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-3156.2003.01012.x","article-title":"Prevalence of typhoid, fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon","volume":"8","author":"Nsutebu","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.066_b0095","first-page":"469","article-title":"Adults' perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children","volume":"25","author":"Chen","year":"2007","journal-title":"J Health Popul Nutr"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2017.09.066_b0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1515\/znc-2000-5-630","article-title":"Prevalence of multi-drug resistant Salmonella typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria","volume":"55","author":"Akinyemi","year":"2000","journal-title":"Z Naturforsch C"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.066_b0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-3156.2008.02031.x","article-title":"Typhoid fever in children in Africa","volume":"13","author":"Mweu","year":"2008","journal-title":"Trop Med Int Health"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.066_b0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Org"},{"issue":"10","key":"10.1016\/j.vaccine.2017.09.066_b0115","article-title":"Seroprevalence of typhoid fever among subjects with acute febrile manifestations at Tertiary Care Center, Addis Ababa, Ethiopia","volume":"3","author":"Weyesa","year":"2014","journal-title":"Int J Sci Res (IJSR)"},{"issue":"12","key":"10.1016\/j.vaccine.2017.09.066_b0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2458-12-523","article-title":"Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases","volume":"16","author":"Falkenhorst","year":"2012","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2017.09.066_b0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tim.2014.06.007","article-title":"Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence","volume":"22","author":"Gunn","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2105\/AJPH.54.3.477","article-title":"Detection of typhoid carriers","volume":"54","author":"Bokkenheuser","year":"1964","journal-title":"Am J Publ Health Nations Health"},{"issue":"8120","key":"10.1016\/j.vaccine.2017.09.066_b0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(79)91316-3","article-title":"Identification of gallbladder typhoid carriers by a string device","volume":"1","author":"Gilman","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.09.066_b0140","article-title":"Rapid detection of typhoid carriers by means of fluorescent antibody techniques","author":"Thomason","year":"1965","journal-title":"Bull World Health Org"},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.066_b0145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3855\/jidc.2561","article-title":"Targeting of putative fimbrial gene for detection of S. Typhi in typhoid fever and chronic typhoid carriers by nested PCR","volume":"7","author":"Pratap","year":"2013","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0150","doi-asserted-by":"crossref","first-page":"e2335","DOI":"10.1371\/journal.pntd.0002335","article-title":"Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal","volume":"7","author":"Charles","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"issue":"7597","key":"10.1016\/j.vaccine.2017.09.066_b0155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bmj.39118.489931.BE","article-title":"Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis","volume":"334","author":"Clasen","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.09.066_b0160","first-page":"161","article-title":"Typhoid fever & vaccine development: a partially answered question","volume":"135","author":"Marathe","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2017.09.066_b0165","unstructured":"Typhoid vaccines. Wkly Epidemiol Rec 2000;75:257\u201364."},{"issue":"31","key":"10.1016\/j.vaccine.2017.09.066_b0170","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.vaccine.2013.05.001","article-title":"Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis","volume":"31","author":"Mitra","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.066_b0175","doi-asserted-by":"crossref","unstructured":"Claire-Anne Siegrist. Vaccine immunology. Chapter 2, Section 1: General aspects of vaccination, pp. 17\u201336.","DOI":"10.1016\/B978-1-4160-3611-1.50006-4"},{"key":"10.1016\/j.vaccine.2017.09.066_b0180","first-page":"164","article-title":"Emergence of Salmonella Typhi Vi antigen-negative strains in an epidemic of multidrug-resistant typhoid fever cases in Calcutta, India","volume":"13","author":"Saha","year":"2000","journal-title":"Natl Med J India"},{"key":"10.1016\/j.vaccine.2017.09.066_b0185","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/JCM.40.2.1127-1128.2002","article-title":"Capsular Vi polysaccharide antigen in Salmonella enterica serovar Typhi isolates","volume":"40","author":"Mehta","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.066_b0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/IAI.39.2.659-665.1983","article-title":"Acute iron overload in mice: pathogenesis of Salmonella typhimurium infection","volume":"39","author":"Sawatzki","year":"1983","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0195","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.1016180108","article-title":"An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development","volume":"108","author":"Ghosh","year":"2011","journal-title":"Proc Natl Acad Sci US A."},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.066_b0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.066_b0205","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2012.08.042","article-title":"A mouse model of Salmonella typhi infection","volume":"151","author":"Mathur","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.09.066_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20081667","article-title":"Inflammasome recognition of influenza virus is essential for adaptive immune responses","volume":"206","author":"Ichinohe","year":"2009","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2017.09.066_b0215","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2017.09.066_b0220","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1093\/clinids\/6.Supplement_2.S361","article-title":"Mucosal immune response to poliovirus vaccines in childhood","volume":"6","author":"Ogra","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.066_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.066_b0230","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/eji.200838506","article-title":"Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC)","volume":"38","author":"Sundstr\u00f6m","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0235","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.066_b0240","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0245","first-page":"197","article-title":"Anomalous observations on IPV and OPV vaccination","volume":"105","author":"John","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2017.09.066_b0250","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.09.066_b0255","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"Haan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.066_b0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.79.1.159-175.2005","article-title":"Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge","volume":"79","author":"Morello","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0265","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1128\/JVI.80.8.3732-3742.2006","article-title":"Systemic immunization with an ALVAC-HIV-1\/protein boost vaccine strategy protects rhesus macaques from CD4_ T-cell loss and reduces both systemic and mucosal SHIVKU2 RNA levels","volume":"80","author":"Pal","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0270","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8_T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.066_b0275","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.181.6.4188","article-title":"Trafficking of antigen-specific CD8_ T lymphocytes to mucosal surfaces following intramuscular vaccination","volume":"181","author":"Kaufman","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0280","first-page":"141","article-title":"Mucosal responses to parenteral and mucosal vaccines","volume":"95","author":"Kaul","year":"1998","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2017.09.066_b0285","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.4049\/jimmunol.178.11.7211","article-title":"A novel functional CTL avidity\/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian\/human immunodeficiency viral depletion of mucosal CD4_T cells","volume":"178","author":"Belyakov","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0290","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1128\/IAI.66.12.5630-5635.1998","article-title":"Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans","volume":"66","author":"Kantele","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.066_b0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1749-6632.1983.tb26866.x","article-title":"The mucosal immunological network: compartmentalization of lymphocytes, natural killer cells, and mast cells","volume":"409","author":"Bienenstock","year":"1983","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2017.09.066_b0300","doi-asserted-by":"crossref","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0305","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0310","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00058-12","article-title":"Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans","volume":"19","author":"Wahid","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0315","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/mi.2015.24","article-title":"Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans","volume":"8","author":"Wahid","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0320","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.066_b0325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.micinf.2014.10.011","article-title":"Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models","volume":"17","author":"Sinha","year":"2015","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0330","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1074\/jbc.M112.408302","article-title":"Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2\/Th17 cell responses","volume":"288","author":"Chatterjee","year":"2013","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.066_b0335","first-page":"562","article-title":"A meningococcal outer membrane vesicle vaccine incorporating genetically attenuated endotoxin dissociates inflammation from immunogenicity","volume":"8","author":"Dowling","year":"2016","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.09.066_b0340","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/apm.12589","article-title":"Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains","volume":"124","author":"Tunheim","year":"2016","journal-title":"APMIS."},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.066_b0345","first-page":"121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"24","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.066_b0350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.11.10","article-title":"Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines","volume":"10","author":"Sanders","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.066_b0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3083.2012.02709.x","article-title":"An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt","volume":"76","author":"Norheim","year":"2012","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.066_b0360","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immun"},{"key":"10.1016\/j.vaccine.2017.09.066_b0365","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ni1004-971","article-title":"The interface between innate and adaptive immunity","volume":"5","author":"Hoebe","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2017.09.066_b0370","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nature Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.09.066_b0375","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3855\/jidc.2495","article-title":"Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi CRM(197) glycoconjugate vaccine against Salmonella Typhi","volume":"6","author":"Rondini","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2017.09.066_b0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0385","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum Vaccin Immun"},{"key":"10.1016\/j.vaccine.2017.09.066_b0390","series-title":"Advisory committee on dangerous pathogens","author":"The Approved List of Biological Agents","year":"2013"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2017.09.066_b0395","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1099\/13500872-141-8-1993","article-title":"Attenuated typhoid vaccine Salmonella typhi Ty21a: fingerprinting and quality control","volume":"141","author":"McKenna","year":"1995","journal-title":"Microbiology"},{"issue":"20","key":"10.1016\/j.vaccine.2017.09.066_b0400","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children","volume":"32","author":"Szu","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.066_b0405","doi-asserted-by":"crossref","DOI":"10.1351\/pac199971050745","article-title":"Bacterial polysaccharide\u00b1protein conjugate vaccines","volume":"71","author":"Robbins","year":"1999","journal-title":"Pure Appl Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.066_b0410","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI112899","article-title":"Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans","volume":"79","author":"Levine","year":"1987","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.066_b0415","first-page":"S20 3","article-title":"CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression","volume":"45","author":"Tacket","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"33 Suppl 3","key":"10.1016\/j.vaccine.2017.09.066_b0420","doi-asserted-by":"crossref","first-page":"C36","DOI":"10.1016\/j.vaccine.2015.04.029","article-title":"Live attenuated vaccines for invasive Salmonella infections","volume":"19","author":"Tennant","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.09.066_b0425","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"phoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.09.066_b0430","doi-asserted-by":"crossref","first-page":"e0004926","DOI":"10.1371\/journal.pntd.0004926","article-title":"Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a","volume":"10","author":"Darton","year":"2016","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T19:54:21Z","timestamp":1603137261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":86,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0264410X17313191"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}